Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sinovac Files to Begin Trials of H7N9 Avian Flu Vaccine

publication date: Jan 29, 2014
Sinovac Biotech has submitted a Clinical Trial Application with the CFDA to begin clinical trials of its avian flu A(H7N9) vaccine. The CFDA accepted the filing today. An outbreak of the H7N9 virus was ended last spring by aggressive action that shut down live poultry markets, but now the virus has returned. So far this year, 96 reported cases of H7N9 flu have caused 20 deaths in China. Once again, poultry markets have been ordered to close in Hong Kong, Shanghai and many other cities. More details....

Stock Symbol: (NSDQ: SVA)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital